Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Guenther Mueller‐Velten"'
Publikováno v:
Biometrics.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cadbc56b905e440f5ccef82cc6112707
https://doi.org/10.1111/biom.13831
https://doi.org/10.1111/biom.13831
Autor:
Thomas R. Fleming, Christine E. Garnett, Laurie S. Conklin, Solange Corriol-Rohou, Sudharshan Hariharan, Daphne Hsu, Guenther Mueller-Velten, Yeruk Mulugeta, Ronald Portman, Mark D. Rothmann, Norman L. Stockbridge, Simon Wandel, Jialu Zhang, Lynne Yao
Publikováno v:
Therapeutic innovationregulatory science. 57(1)
Even with recent substantive improvements in health care in pediatric populations, considerable need remains for additional safe and effective interventions for the prevention and treatment of diseases in children. The approval of prescription drugs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c40989891b158eea2f9b1ca62e1fb45f
https://pubmed.ncbi.nlm.nih.gov/36057747
https://pubmed.ncbi.nlm.nih.gov/36057747
Autor:
Norman Stockbridge, Bruce Binkowitz, Mouna Akacha, H. M. James Hung, Guenther Mueller-Velten, Brian Claggett
Publikováno v:
Therapeutic Innovation & Regulatory Science. 53:387-397
Serious and chronic health conditions such as cardiovascular diseases (CVDs) are posing challenges to the health system. Recently clinical trials in these fields have focused on composite endpoints that take into account both disease-related mortalit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9bc3d7fa4dd213fd4b89378f67e7bda9
https://doi.org/10.1177/2168479018784912
https://doi.org/10.1177/2168479018784912
Autor:
Michael R. Zile, Jean L. Rouleau, Lars Køber, Ulrik M. Mogensen, Karl Swedberg, Brian Claggett, Li Shen, Martin Lefkowitz, John J.V. McMurray, Jianjian Gong, Pardeep S. Jhund, Scott D. Solomon, Guenther Mueller-Velten, Milton Packer, Akshay S. Desai
Publikováno v:
European Journal of Heart Failure. 20:760-768
Aims Recurrent hospitalizations are a major part of the disease burden in heart failure (HF), but conventional analyses consider only the first event. We compared the effect of sacubitril/valsartan vs. enalapril on recurrent events, incorporating all
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::41227a4dca400eeb981bb61cd2758c28
https://doi.org/10.1002/ejhf.1139
https://doi.org/10.1002/ejhf.1139
Autor:
Dimitris Tousoulis, Pieter A. de Graeff, Guenther Mueller-Velten, Jeroen J. Bax, Warren Sherman, Thomas Severin, Giuseppe M.C. Rosano, Ian Ford, Marcus Flather, Gerasimos Filippatos, Wendy Gattis Stough, Stefan D. Anker, Barry H. Greenberg, John Lekakis, Tim Friede, Panagiotis Vardas, Luigi Tavazzi, Karl Swedberg, Frank Ruschitzka, John Joseph Borg, Richard Holcomb, Bradley Horst, Henry J. Dargie, Athanasios G. Papavassiliou, Krishna Prasad, John G.F. Cleland, Cécile Henon-Goburdhun
Publikováno v:
European Journal of Heart Failure. 19:449-456
Data Monitoring Committees (DMCs) play a crucial role in the conducting of clinical trials to ensure the safety of study participants and to maintain a trial's scientific integrity. Generally accepted standards exist for DMC composition and operation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2deebfc9d13c701704edcbd1b96ee9b3
https://doi.org/10.1002/ejhf.761
https://doi.org/10.1002/ejhf.761
Autor:
William T. Abraham, Michael R. Zile, Jean L. Rouleau, Guenther Mueller-Velten, Lars Køber, Mark C. Petrie, Scott D. Solomon, Brian Claggett, Joanne Simpson, Li Shen, Milton Packer, John J.V. McMurray, Akshay S. Desai, Pardeep S. Jhund, Sandosh Padmanabhan, Lars H. Lund, Karl Swedberg, Kenneth Dickstein
Publikováno v:
JAMA Cardiol
Importance: Accurate prediction of risk of death or hospitalizations in patients with heart failure (HF) may allow physicians to explore how more accurate decisions regarding appropriateness and timing of disease-modifying treatments, advanced therap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41768a532a20e6864b952375c5f4c742
https://acuresearchbank.acu.edu.au/item/8vz6q/prognostic-models-derived-in-paradigm-hf-and-validated-in-atmosphere-and-the-swedish-heart-failure-registry-to-predict-mortality-and-morbidity-in-chronic-heart-failure
https://acuresearchbank.acu.edu.au/item/8vz6q/prognostic-models-derived-in-paradigm-hf-and-validated-in-atmosphere-and-the-swedish-heart-failure-registry-to-predict-mortality-and-morbidity-in-chronic-heart-failure
Autor:
Ulrik M, Mogensen, Jianjian, Gong, Pardeep S, Jhund, Li, Shen, Lars, Køber, Akshay S, Desai, Martin P, Lefkowitz, Milton, Packer, Jean L, Rouleau, Scott D, Solomon, Brian L, Claggett, Karl, Swedberg, Michael R, Zile, Guenther, Mueller-Velten, John J V, McMurray
Publikováno v:
European Journal of Heart Failure
Aims Recurrent hospitalizations are a major part of the disease burden in heart failure (HF), but conventional analyses consider only the first event. We compared the effect of sacubitril/valsartan vs. enalapril on recurrent events, incorporating all
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::abbede94d18cbba3408b1462afb50336
https://pubmed.ncbi.nlm.nih.gov/29431251
https://pubmed.ncbi.nlm.nih.gov/29431251
Autor:
John R. Teerlink, Beth A. Davison, Barry H. Greenberg, Marco Metra, Sam L. Teichman, Adriaan A. Voors, G. Michael Felker, Thomas Severin, Guenther Mueller-Velten, Gerasimos Filippatos, Piotr Ponikowski, Elaine Unemori, Gad Cotter
Publikováno v:
American Heart Journal, 163(2), 149-U234. MOSBY-ELSEVIER
Background Acute heart failure (AHF) remains a major public health burden with a high prevalence and poor prognosis. Relaxin is a naturally occurring peptide hormone that increases cardiac output, arterial compliance, and renal blood flow during preg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f08f8eec454b21b6cc6a5eb281aed8a
https://doi.org/10.1016/j.ahj.2011.10.009
https://doi.org/10.1016/j.ahj.2011.10.009
Autor:
Bruce A. Schwartz, Bruce M. Ewenstein, Stephanie Seremetis, Amy D. Shapiro, Martin Broder, Cindy A. Leissinger, Guenther Mueller-Velten, Thomas Hofstra, J Heinrich Joist
Publikováno v:
Transfusion. 42(2)
BACKGROUND: Hemophilia B is an X-linked bleeding disorder that affects approximately 1 in 25,000 males. Therapy for acute bleeding episodes consists of transfusions of plasma-derived (pd-F IX) or recombinant (r-F IX) concentrates. STUDY DESIGN AND ME
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::714c37d653f2ebd9f0e5369a8fe5313e
https://pubmed.ncbi.nlm.nih.gov/11896334
https://pubmed.ncbi.nlm.nih.gov/11896334
Autor:
Thomas C. Naslund, Glenn C. Hunter, Ronald A. Kline, Guenther Mueller-Velten, Allen Koslow, Lloyd M. Taylor
Publikováno v:
Journal of Vascular Surgery. (4):766-771
ObjectiveWe evaluated the safety and efficacy of the fibrin sealant Beriplast P (FSBP; Aventis-Behring) for hemostasis in anastomosis of polytetrafluoroethylene (PTFE) grafts to the femoral artery.MethodsIn a single-blinded randomized prospective mul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f2342f30611bc62969a8ed2d7879901